## SJM: The J.M. Smucker Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 2.9% below STRENGTH zone (3.0-6.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($97.24)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 1, Bearish: 1)

**1. Is J. M. Smucker Stock Underperforming the Dow?**
- Source: Markets Financial Content | 20251216T120911 | Somewhat-Bearish | Relevance: 100%
- The J. M. Smucker Company (SJM) stock has underperformed the Dow Jones Industrials Average ($DOWI) over the past three months and the last year, despite a 6.2% rise on a six-month basis. SJM is trading below its 200-day and 50-day moving averages, and recently missed Wall Street's adjusted EPS expectations for Q2. However, analysts maintain a "Moderate Buy" rating with a potential upside of 16.2%.

**2. This Southern State Is Home To The World's Largest Peanut Butter Factory**
- Source: Tasting Table | 20251215T190833 | Bullish | Relevance: 100%
- The world's largest peanut butter factory, which produces Jif peanut butter, is located in Lexington, Kentucky. The J.M. Smucker Company facility, originally built in 1946, processes an estimated 250,000 containers of peanut butter daily and has undergone significant expansions over the years. This factory plays a major role in the country's peanut butter supply, with a significant portion of all Jif consumed in the U.S. originating from this Kentucky plant.

**3. Balyasny Asset Management L.P. Acquires 703,382 Shares of The J. M. Smucker Company $SJM**
- Source: MarketBeat | 20251213T090807 | Somewhat-Bearish | Relevance: 100%
- Balyasny Asset Management L.P. significantly increased its stake in The J. M. Smucker Company (SJM) by 45.4%, acquiring an additional 703,382 shares, bringing its total holding to 2,251,934 shares valued at $221.14 million. This makes SJM its 21st largest holding, representing about 2.11% of the company and 0.3% of the fund's portfolio. The acquisition occurred despite the company missing Q3 EPS estimates by $0.02, though revenue grew 2.6% year-over-year.

**4. What J. M. Smucker (SJM)'s Mixed Quarter and Soft Guidance Means For Shareholders**
- Source: Simply Wall Street | 20251214T130848 | Bearish | Relevance: 100%
- J. M. Smucker reported a mixed quarter with 2.6% revenue growth matching expectations and stronger gross margins, but full-year earnings guidance fell below analyst forecasts. This highlights persistent profitability pressures and questions surrounding the effectiveness of its growth initiatives. The company's slow organic revenue progress, falling operating margins, and low returns on invested capital suggest an uneven path to healthier operating margins despite resilient top-line performance.

**5. What J. M. Smucker (SJM)'s Mixed Quarter and Soft Guidance Means For Shareholders**
- Source: Simply Wall Street | 20251214T132224 | Somewhat-Bearish | Relevance: 97%
- J. M. Smucker reported mixed Q4 results with revenue matching expectations and improved gross margins, but full-year earnings guidance fell short of analyst forecasts. The company faces ongoing profitability challenges due to slow organic revenue growth, declining operating margins, and low returns on invested capital. The guidance miss suggests an uneven path to healthier operating margins despite management's positive outlook.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | JP Morgan | $121 | $122 | -1% |
| 2025-11-26 | UBS | $117 | $120 | -2% |
| 2025-11-26 | Morgan Stanley | $115 | $118 | -3% |
| 2025-11-26 | Stifel | $110 | $115 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | JP Morgan | main | Overweight |
| 2025-11-26 | UBS | main | Buy |
| 2025-11-26 | Morgan Stanley | main | Overweight |
| 2025-11-26 | Stifel | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 4 ($1.92M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (-3.1%)
- Blackrock Inc.: 8.1% (+1.4%)
- State Street Corpora: 6.7% (-3.0%)
- Barclays Plc: 3.7% (+386.9%)
- Geode Capital Manage: 2.7% (+1.7%)

### Key Risks

1. Long-term trend broken: trading 6.1% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +5.5% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Analyst sentiment negative (4 target cuts vs 1 raises). Insider selling cluster ($1.9M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.8B |
| Beta | 0.21 |
| 52W Range | $93.30 - $121.48 |
| Short Interest | 7.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 12.7 |
| Current P/E | 11.3 |
| YoY Growth | -11.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.5% to 2.9% (+5.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.1pp (needs >3.0% for momentum thesis). MRS_5 at 2.6% confirms short-term momentum alignment. Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 46. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.92% (CS: 61) | Neutral |
| RSI_14 | 46.3 | Neutral |
| MACD Histogram | 0.01 | Bullish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 0.978x | Below |
| vs SMA200 | 0.939x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $101.68
- **Stop Loss:** $97.24 (4.4% risk)
- **Target:** $106.12 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 270
- **Position Value:** $27,453.60
- **Portfolio %:** 27.45%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-26 (Est: $2.26)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.10 | $2.10 | -0.0% |
| 2025Q3 | $1.93 | $1.90 | -1.4% |
| 2025Q2 | $2.25 | $2.31 | +2.8% |
| 2025Q1 | $2.37 | $2.61 | +10.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*